Immunovant, Inc. (IMVT) Earnings
NASDAQ·Healthcare·Biotechnology
$37.40
-1.86%
Mkt Cap $8.10B
EPS — Estimate vs Actual
Mkt Cap
$8.10B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.78
NASDAQ·Healthcare·Biotechnology
$37.40
-1.86%
Mkt Cap $8.10B
Mkt Cap
$8.10B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.78